Inclusion criteria
|
1) The subjects of 18–75 years old |
2) Migraine with or without aura (ICHD-3beta code1.1 or 1.2.1.1) and at least 2 attacks and 4 days of migraine days per month |
3) The subjects who are using acute medicine and/or prophylactic medicine without changing the prescription for the last three months |
4) The subjects from whom informed consent has been obtained |
Exclusion criteria
|
1) Subjects who changed their prophylaxis within the previous 3 months |
2) Subjects who received BOTOX or a nerve block within the previous 3 months |
3) Subjects with any secondary headache except for MOH |
4) Subjects who have severe neurologic and/or psychiatric disorders |
5) Subjects who have epilepsy |
6) Pregnant or breast-feeding women |
7) Subjects who have severe heart, liver, and/or renal dysfunction |
8) Subjects who are using opioids |
9) Subjects who have allodynia |
10) Subjects who have metal and/or electrical device in their body |
11) Subjects who are using a cardiac pacemaker and/or implantable cardioverter-defibrillator |
12) Subjects whom investigators consider to be ineligible |